Literature DB >> 7479976

Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination.

D C Scherer1, J A Brockman, Z Chen, T Maniatis, D W Ballard.   

Abstract

The inhibitor protein I kappa B alpha controls the nuclear import of the transcription factor NF-kappa B. The inhibitory activity of I kappa B alpha is regulated from the cytoplasmic compartment by signal-induced proteolysis. Previous studies have shown that signal-dependent phosphorylation of serine residues 32 and 36 targets I kappa B alpha to the ubiquitin-proteasome pathway. Here we provide evidence that lysine residues 21 and 22 serve as the primary sites for signal-induced ubiquitination of I kappa B alpha. Conservative Lys-->Arg substitutions at both Lys-21 and Lys-22 produce dominant-negative mutants of I kappa B alpha in vivo. These constitutive inhibitors are appropriately phosphorylated but fail to release NF-kappa B in response to multiple inducers, including viral proteins, cytokines, and agents that mimic antigenic stimulation through the T-cell receptor. Moreover, these Lys-->Arg mutations prevent signal-dependent degradation of I kappa B alpha in vivo and ubiquitin conjugation in vitro. We conclude that site-specific ubiquitination of phosphorylated I kappa B alpha at Lys-21 and/or Lys-22 is an obligatory step in the activation of NF-kappa B.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479976      PMCID: PMC40611          DOI: 10.1073/pnas.92.24.11259

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Activation of NF-kappa B requires proteolysis of the inhibitor I kappa B-alpha: signal-induced phosphorylation of I kappa B-alpha alone does not release active NF-kappa B.

Authors:  Y C Lin; K Brown; U Siebenlist
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

Review 2.  The ubiquitin-proteasome proteolytic pathway.

Authors:  A Ciechanover
Journal:  Cell       Date:  1994-10-07       Impact factor: 41.582

3.  Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain.

Authors:  M Treier; L M Staszewski; D Bohmann
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

Review 4.  The I kappa B proteins: members of a multifunctional family.

Authors:  T D Gilmore; P J Morin
Journal:  Trends Genet       Date:  1993-12       Impact factor: 11.639

Review 5.  Function and activation of NF-kappa B in the immune system.

Authors:  P A Baeuerle; T Henkel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

6.  Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors.

Authors:  T S Finco; A A Beg; A S Baldwin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

7.  Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B.

Authors:  S Miyamoto; M Maki; M J Schmitt; M Hatanaka; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

8.  Proteolytic processing of NF-kappa B/I kappa B in human monocytes. ATP-dependent induction by pro-inflammatory mediators.

Authors:  R Donald; D W Ballard; J Hawiger
Journal:  J Biol Chem       Date:  1995-01-06       Impact factor: 5.157

9.  Ligand-induced desensitization of interleukin 1 receptor-initiated intracellular signaling events in T helper lymphocytes.

Authors:  D J McKean; C Huntoon; M Bell
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

10.  A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B.

Authors:  E B Traenckner; S Wilk; P A Baeuerle
Journal:  EMBO J       Date:  1994-11-15       Impact factor: 11.598

View more
  169 in total

Review 1.  Control of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alpha.

Authors:  R T Hay; L Vuillard; J M Desterro; M S Rodriguez
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-09-29       Impact factor: 6.237

2.  c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.

Authors:  M A Gregory; S R Hann
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  SCF(beta)(-TrCP) ubiquitin ligase-mediated processing of NF-kappaB p105 requires phosphorylation of its C-terminus by IkappaB kinase.

Authors:  A Orian; H Gonen; B Bercovich; I Fajerman; E Eytan; A Israël; F Mercurio; K Iwai; A L Schwartz; A Ciechanover
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

4.  Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.

Authors:  M S Rodriguez; J M Desterro; S Lain; D P Lane; R T Hay
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

5.  Interaction between hnRNPA1 and IkappaBalpha is required for maximal activation of NF-kappaB-dependent transcription.

Authors:  D C Hay; G D Kemp; C Dargemont; R T Hay
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

6.  Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.

Authors:  Daniela Boehm; Benjamin E Gewurz; Elliott Kieff; Ellen Cahir-McFarland
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-05       Impact factor: 11.205

7.  Role of ascorbate in the activation of NF-kappaB by tumour necrosis factor-alpha in T-cells.

Authors:  E Muñoz; M V Blázquez; C Ortiz; C Gomez-Díaz; P Navas
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

8.  NF-kappa B signaling promotes both cell survival and neurite process formation in nerve growth factor-stimulated PC12 cells.

Authors:  E D Foehr; X Lin; A O'Mahony; R Geleziunas; R A Bradshaw; W C Greene
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

9.  I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity.

Authors:  S T Whiteside; J C Epinat; N R Rice; A Israël
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

10.  Increased IkappaB alpha expression is essential for the tolerogenic property of TGF-beta-exposed APCs.

Authors:  Paiman Ghafoori; Takeru Yoshimura; Bruce Turpie; Sharmila Masli
Journal:  FASEB J       Date:  2009-02-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.